Evidence map›Paper›PMID 38926348›Full record

ArticleNature communications2024

Comparative optimization of polysaccharide-based nanoformulations for cardiac RNAi therapy.

Han Gao, Sen Li, Zhengyi Lan, Da Pan, Gonna Somu Naidu, Dan Peer, Chenyi Ye, Hangrong Chen, Ming Ma, Zehua Liu and 1 more

Abstract readComparative Study
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. The RNA delivery dilemma-lipid versus polymer nanoparticle platforms.Drug delivery and translational research · 2026
    Article
  2. Review
  3. Article
  4. Design andMaterials today. Bio · 2026
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Han Gao *Department of Biomaterials and Biomedical Technology, University Medical Center Groningen (UMCG), The Personalized Medicine Research Institute (PRECISION), University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, The Netherlands.
Sen Li *Department of Vascular Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
Zhengyi LanShanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, China.
Da PanKey Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing, 210009, China.ORCID 0000-0001-8430-9467
Gonna Somu NaiduLaboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 69978, Israel.
Dan PeerLaboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 69978, Israel.ORCID 0000-0001-8238-0673
Chenyi YeDepartment of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
Hangrong ChenShanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, China.ORCID 0000-0003-0827-1270
Ming MaShanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, China. mma@mail.sic.ac.cn.ORCID 0000-0002-1068-4528
Zehua LiuDepartment of Biomaterials and Biomedical Technology, University Medical Center Groningen (UMCG), The Personalized Medicine Research Institute (PRECISION), University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, The Netherlands. zehua.liu@helsinki.fi.ORCID 0000-0002-4158-9072
Hélder A SantosDepartment of Biomaterials and Biomedical Technology, University Medical Center Groningen (UMCG), The Personalized Medicine Research Institute (PRECISION), University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, The Netherlands. h.a.santos@umcg.nl.ORCID 0000-0001-7850-6309

Funding

Academy of Finland (Suomen Akatemia) 331151
6 · The paper itself

Abstract

Ionotropic gelation is widely used to fabricate targeting nanoparticles (NPs) with polysaccharides, leveraging their recognition by specific lectins. Despite the fabrication scheme simply involves self-assembly of differently charged components in a straightforward manner, the identification of a potent combinatory formulation is usually limited by structural diversity in compound collections and trivial screen process, imposing crucial challenges for efficient formulation design and optimization. Herein, we report a diversity-oriented combinatory formulation screen scheme to identify potent gene delivery cargo in the context of precision cardiac therapy. Distinct categories of cationic compounds are tested to construct RNA delivery system with an ionic polysaccharide framework, utilizing a high-throughput microfluidics workstation coupled with streamlined NPs characterization system in an automatic, step-wise manner. Sequential computational aided interpretation provides insights in formulation optimization in a broader scenario, highlighting the usefulness of compound library diversity. As a result, the out-of-bag NPs, termed as GluCARDIA NPs, are utilized for loading therapeutic RNA to ameliorate cardiac reperfusion damages and promote the long-term prognosis. Overall, this work presents a generalizable formulation design strategy for polysaccharides, offering design principles for combinatory formulation screen and insights for efficient formulation identification and optimization.

Indexed as

NanoparticlesPolysaccharidesAnimalsGene Transfer TechniquesHumansMaleMiceMice, Inbred C57BLMyocardial Reperfusion InjuryRNA InterferenceRNAi TherapeuticsRNA, Small InterferingPolysaccharidesRNA, Small Interfering

Identifiers

PMID38926348
PMCPMC11208445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.